Nab-paclitaxel Based Regimens VS Paclitaxel Based Regimens in Neoadjuvant Treatment for TNBC
Status: WITHDRAWN
Study type: INTERVENTIONAL
Conditions: Triple Negative Breast Cancer
Interventions: DRUG: Albumin bound (nab)-paclitaxel combined with carboplatin followed by epirubicin and cyclophosphamide|DRUG: paclitaxel combined with carboplatin followed by epirubicin and cyclophosphamide
Sponsor: Hebei Medical University Fourth Hospital